Evidence map›Paper›PMID 39108878›Full record

ArticleHeliyon2024

Development of an active agar aerogel with dual antioxidant and UV-blocking activities using chlorine-doped graphene quantum dots.

Kimia Taji, Hajar Shekarchizadeh

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kimia TajiDepartment of Food Science and Technology, College of Agriculture, Isfahan University of Technology, Isfahan, Iran.
Hajar ShekarchizadehDepartment of Food Science and Technology, College of Agriculture, Isfahan University of Technology, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Active packaging is of great interest in the modern food industry due to increasing shelf life and enhancing food quality. The importance of this technology increases when natural polymers are used in the construction of active packages. Development of a natural, biodegradable, and dual-active film was aimed in this study. So, agar aerogel containing different amounts of chlorine-doped graphene quantum dots (Cl-GQDs) was prepared. Cl-GQDs had excitation-dependent fluorimetry behavior due to the zigzag edges of graphene. The mean diameter of spherical nanoparticles of Cl-GQDs was about 12 nm, according to HR-TEM images. The results of Raman and ATR-FTIR confirmed that chlorine was well-doped on the GQD structure. Cl-GQDs showed high UV-absorption capability and very strong antioxidant activity (94.31 %), which maintained these activities after incorporation into the agar aerogel. The doped chlorine was responsible for the capacity to charge transfer of GQDs. BET and SEM results showed that adding Cl-GQDs to agar caused a porous structure. Finally, different types of agar aerogels containing Cl-GQDs can be used considering the intended application of aerogel. Agar aerogel containing 20 % Cl-GQDs is suggested if a porous aerogel with good thermal insulation properties is considered. However, agar aerogel containing 1 % Cl-GQDs is suitable as an active film. In conclusion, while Cl-GQDs hold promise as sustainable and multifunctional food packaging materials, their potential toxic effects must be thoroughly evaluated. Future studies should explore migration, potential interactions with specific food matrices, and long-term safety to ensure consumer protection.

Indexed as

Active packagingAerogelAntioxidantAnti-ultraviolet radiationCl-GQDsHydrothermal

Identifiers

PMID39108878
PMCPMC11301348

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.